Latest News about Phytopharm's Hoodia Gordonii Product

It wasn't just media news that caused supplementstrategy advances to the search for a partner
companies to begin looking for hoodia gordoniicompany for "late stage development, sales and
supplies. Press releases by Phytopharm, a Britishmarketing". The partner company for Phytopharm's
pharmaceutical company, about researching hoodiahoodia gordonii product is Unilever, manufacturers of
and side effects that might be associated withfood products, dietary supplements and over the
hoodia caused the initial stir in the health supplementcounter medications. One of their more famous
industry.products is "Slim Fast". Phytopharm is still researching
Phytopharm has two operating divisions; a plantand investigating the possibility or a drug to treat
extract division and a pharmaceutical division. In Junemetabolic disorder and hoodia gordonii is the basis for
of 1997, Phytopharm announced that "a naturallythis drug.
occurring appetite suppressant is to be developedPhytopharm attempts to obtain patents for naturally
into a prescription medicine by Phytopharm". This wasoccurring substances. "Phytopica" is a Phytopharm
to be Phytopharm's hoodia gordonii product. News ofproduct for the treatment of dermatitis in dogs and
a naturally occurring appetite suppressant sent, notwas just released in April of 2006. Phytopharm's
only supplement companies, but those who neededhoodia gordonii product is patented, but they have
to lose weight searching for this "naturally occurringhad more than a little trouble keeping other
appetite suppressant". At that time, everyonemanufacturers of natural products from selling their
expected Phytopharm's hoodia gordonii product to beown hoodia products. In May of 2006, they
a prescription drug even though it was consistentlyannounced that they were aware that other
referred to by the company as a "natural anti-obesitycompanies were selling hoodia gordonii as an appetite
treatment". Their collaboration with Pfizer, anothersuppressant and that they believed that this could be
pharmaceutical company, to research hoodia and sidepatent infringement. They said that they had
effects that could be caused by hoodia use onlycontacted the appropriate authorities. The problem is
supported the idea that Phytopharm's hoodia gordoniithat a naturally occurring product can not be
would be a prescription drug. Now, since they havepatented. If Phytopharm's hoodia gordonii product is
partnered with Unilever, not a pharmaceuticalunique and therefore stronger, safer and better than
company, it is somewhat unclear what Phytopharm'sthe hoodia products that are currently on the
hoodia gordonii product will be. They do seemmarket, then how could there be patent infringement
committed to the idea that Phytopharm's hoodiaand why would they be concerned about companies
gordonii will be superior to products that are currentlythat are selling what they imply are inferior products?
on the market.There is no comparison between the known side
Phytopharm's product development strategy beginseffects of hoodia and side effects associated with
with what they call "proof of principle" clinical testing.appetite suppressants that contain stimulants.
These tests are designed to determine if a productProducts which contain both hoodia and stimulants
has the potential to be safe and effective. Proof ofcould create a problem. It is believed that problems
principle testing of Phytopharm's hoodia gordoniiwith Ephedra arose as a result of being mixed with
product began in March of 2001. News about hoodiacaffeine or other stimulants. The problem was that
and side effects were released after this first phasethis could not be proven without endangering human
was completed in December of 2001. This was ahealth. Hopefully, Phytopharm's hoodia gordonii
naturally occurring substance and there appeared toproduct will be stimulant free as are many of the
be no side effects associated with its use. Afterhoodia products that are currently on the market.
completing the initial clinical testing, Phytopharm's